National Priority Vouchers aim to shorten FDA review from ~10–12 months to ~1–2 months using collaborative multidisciplinary ...

A UC Health system-wide hypertension medication algorithm improved blood pressure control across tens of thousands of ...

Major health insurers say they have cut prior authorizations, but the AMA says physicians report that the burden of prior ...

Providers and payers certainly face some formidable challenges when it comes to gene therapy, but it pales in comparison to ...

Bronchoscopy-based lower airway sequencing showed higher resistome abundance and diversity in COPD, bronchiectasis, and ...

The FDA has granted an accelerated approval for Otarmeni (lunsotogene parvec-cwha), the first gene therapy to treat patients ...

Skin cells can actively help the rabies virus multiply and pass into nearby nerve cells, explaining how even small bites or ...

Multiple myeloma accounts for only 1.8% of cancers, but it is the second-most common blood cancer, with approximately 36,000 ...

See how 2026 ADA guidance broadens CGM use beyond insulin, urges payer coverage, and highlights kids, pregnancy, and older ...

Idvynso uniquely offers a two-drug, tenofovir-free, non-INSTI single-tablet regimen intended for switch in stable, suppressed ...

Optum Health posted $1.3B adjusted earnings and cited dual-eligible value-based care associations with fewer admissions and ...

A study in JAMA Dermatology found that people using an AI tool were more accurate and confident in identifying skin ...